home.aspx

 
.

DEVELOPING AN ASSAY PLATFORM FOR SCREENING AND CHARACTERIZATION OF ANTIBODY DRUG CONJUGATES

September 12, 2019 | (07:00)
UK (United Kingdom)
Antibody-drug conjugates (ADCs) are increasingly being designed and used as highly targeted cancer therapies - a modern "magic bullet" approach. They consist of an antibody conjugated to a cytotoxic drug via a chemical linker, thereby enabling delivery of the toxic payload to cancer cells expressing a surface antigen of interest.